These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21168043)

  • 21. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on ivabradine for heart failure.
    Borer JS; Tavazzi L
    Trends Cardiovasc Med; 2016 Jul; 26(5):444-9. PubMed ID: 26934996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ivabradine: Role in the Chronic Heart Failure Armamentarium.
    Psotka MA; Teerlink JR
    Circulation; 2016 May; 133(21):2066-75. PubMed ID: 27217432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ivabradine approved for stable chronic heart failure.
    Traynor K
    Am J Health Syst Pharm; 2015 Jun; 72(11):896. PubMed ID: 25987676
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial.
    Böhm M; Robertson M; Borer J; Ford I; Komajda M; Mahfoud F; Ewen S; Swedberg K; Tavazzi L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT.
    Voors AA; van Veldhuisen DJ; Robertson M; Ford I; Borer JS; Böhm M; Komajda M; Swedberg K; Tavazzi L;
    Eur J Heart Fail; 2014 Apr; 16(4):426-34. PubMed ID: 24504937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure].
    Bruhn C
    Med Monatsschr Pharm; 2012 Jun; 35(6):202-8. PubMed ID: 22808664
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials.
    Mengesha HG; Weldearegawi B; Petrucka P; Bekele T; Otieno MG; Hailu A
    BMC Cardiovasc Disord; 2017 Apr; 17(1):105. PubMed ID: 28454527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Coronary heart disease. Rapid heart rate has an unfavorable prognosis].
    Einecke D
    MMW Fortschr Med; 2008 Sep; 150(38):12-4. PubMed ID: 18983046
    [No Abstract]   [Full Text] [Related]  

  • 31. Ivabradine in heart failure--no paradigm SHIFT…yet.
    Teerlink JR
    Lancet; 2010 Sep; 376(9744):847-9. PubMed ID: 20801501
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ivabradine, an I(f) current inhibitor--new treatment options in coronary heart disease].
    Mach F
    Rev Med Suisse; 2009 May; 5(205):1168-70, 1172-3. PubMed ID: 19517748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New data support ivabradine use in chronic heart failure.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):216-7. PubMed ID: 21881692
    [No Abstract]   [Full Text] [Related]  

  • 34. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine.
    Komajda M
    Handb Exp Pharmacol; 2017; 243():167-175. PubMed ID: 27752846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y; Mert U; Nadir A; Mutlu F; Morrad B; Ulus T
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):603-9. PubMed ID: 24922198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations on a Precision Medicine Theme: One Size Fits Some.
    Hauptman PJ; Gong TA; Vidic A
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27470498
    [No Abstract]   [Full Text] [Related]  

  • 38. Ivabradine: Do the Benefits Outweigh the Risks?
    Alshammari TM
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):210-218. PubMed ID: 27698078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivabradine: beyond heart rate control.
    Riccioni G; Vitulano N; D'Orazio N
    Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
    Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
    Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.